Hard work more powerful than Harvard: PM Modi

March 1, 2017

Maharajganj (UP), Mar 1: Mocking economists, Prime Minister Narendra Modi today said "hard work is more powerful than Harvard" as the latest GDP data shows demonetisation did not affect growth rate, rather the figures improved.

modi"On the one hand are those (critics of note ban) who talk of what people at Harvard say and on the other hand is a poor man's son who through his hard work is trying to improve the economy," he said at an election meeting here.

"In fact, hard work is much more powerful than Harvard" he said without elaborating.

His remark came against the backdrop of Professor of Economics and Philosophy at Harvard University and Nobel Laureate Amartya Sen terming demonetisation as a "despotic action that has struck at the root of economy based on trust".

The government had yesterday pegged GDP growth at a higher-than-expected 7.1 per cent for 2016-17 despite the cash blues, which was higher than China's 6.8 per cent for Oct-Dec period of 2016, making India retain the tag of the world's fastest growing economy.

Coming back to electoral politics in Uttar Pradesh, Modi said the electorate has already ensured BJP's victory in the first five phases and now they would give surplus votes as "gift and bonus" in the remaining two rounds.

"I request the voters of the state to give the rest of the two phases as bonus to the party. This is similar to the chillies and coriander leaves, which the vegetable seller gives to the buyer as bonus," he said drawing applause from the crowd.

A few days back the Prime Minister had spoken of the possibility of a hung assembly in the state, saying SP and BSP were waiting for such an opportunity for bargaining, prompting Chief Minister Akhilesh Yadav to comment that after dreaming of 300 plus seats, Modi was now talking about fractured verdict.

Comments

s
 - 
Thursday, 2 Mar 2017

this mad man is going to destroy the country

Yaseen Baig
 - 
Wednesday, 1 Mar 2017

Wondering if this statement insults prestigious Harvard University!

Althaf
 - 
Wednesday, 1 Mar 2017

Dear Bol Bacchan Modi
Instead of wasting your time on bakwaas speeches and lies do some hard work towards the development of country.

Rikaz
 - 
Wednesday, 1 Mar 2017

Modiji, dont say that you got fake degree certificates....it does not look nice from you being a PM.....

Used your Hard work to kill 3000 Muslims in Gujrath.....shame on you....

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 8,2020

New Delhi, May 8: The Supreme Court on Friday suggested that states should consider indirect sale and home delivery of liquor as per its statute and law to avoid crowding at liquor shops amid the ongoing coronavirus-induced lockdown.

A bench headed by Justice Ashok Bhushan refused to pass any orders on a public interest litigation (PIL) seeking clarity on the sale of liquor and to ensure social distancing while it is being sold in liquor shops during the lockdown.

"We will not pass any order but the states should consider indirect sale/home delivery of liquor to maintain social distancing norms and standards," Justice Ashok Bhushan said while disposing of the petition.

The PIL, filed by one Sai Deepak, sought directions for closure of liquor shops for failing to enforce social distancing, which is essential to prevent the spread of coronavirus.

The petitioner told the apex court that he only wants that the life of common people is not affected because of crowding at liquor shops during COVID-19.

Justice Sanjay Kishan Kaul, another judge in the bench, said that discussion on home delivery is already going on.

The top court, after hearing the petition complaining about flouting of safety norms at liquor shops, observed that it cannot pass any orders to different states but they should consider online sale and home delivery of liquor.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 29,2020

Thiruvananthapuram, Mar 29: Kerala Chief Minister Pinarayi Vijayan on Saturday expressed his concern over the ''non-cooperation from the Karnataka Government in removing the roadblocks erected by them in the roads bordering Malapuram district''.

Addressing a press conference at the Government Secretariat, the Chief Minister said, "Karnataka has not heeded to our request to remove the roadblocks. I have been trying to contact their Chief Minister B S Yeddyurappa but not able to reach him."

"We have briefed the Union Minister D V Sadananda Gowda and he has offered to resolve the issue. Our Chief Secretary has also briefed the Central Cabinet Secretary and we expect a resolution soon," he added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.